Pharsight to Support FDA s Critical Path Initiative

genomeweb
360dx

Pharsight to Support FDA s Critical Path Initiative

Jun 07, 2006

NEW YORK, June 7 (GenomeWeb News) - Pharsight has entered into a Cooperative Research and Development Agreement with the US Food and Drug Administration's Center for Drug Evaluation and Research, the firms said today.

To read the full story....

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Illumina Q1 2018 Revenues Rise 31 Percent
ABRF Single-Cell RNA-Seq Platform Comparison Finds Similar Performance, Drawbacks for Each
Sweet Wormwood Genome Provides Clues for Boosting Production of Antimalarial Compound
VC Aspire Universal Forms Personalized Medicine Investment Fund
Freenome, Biognosys Partner on Early Cancer Detection
Loss-of-Function, Truncating Variants in UK Biobank Data Point to New Drug Targets

The Scan

Here We Are Again

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

Main menu